ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.00
0.71%
US Tech 100
21,602.00
0.35%
S&P 500
6,129.58
0.24%
US Dollar vs CAD
1.41891
-0.01%
Bitcoin
95,500.93
-0.07%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) News

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTBP
DateTimeSourceHeadlineSymbolCompany
02/07/20258:32AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
01/27/20257:31AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
01/27/20256:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
12/23/20244:23PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GTBPGT Biopharma Inc
11/27/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
11/21/20248:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
11/14/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
10/21/20248:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
10/17/202410:15AMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GTBPGT Biopharma Inc
09/16/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
06/17/20243:26PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
06/13/20243:14PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
06/07/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
05/23/20247:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
05/23/20245:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
05/23/20245:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
05/15/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
02/14/20241:46PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
02/01/202411:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
12/21/20232:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
12/04/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
11/06/20234:25PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
11/06/20234:23PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
11/06/20234:21PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
11/01/20238:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
10/27/20234:23PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
09/19/202310:56AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
08/22/20233:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
08/15/20236:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
08/15/20236:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:GTBP

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
NASDAQ
NVDA
NVIDIA
USOTC
CLNV
Clean Vision (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
MGON
Megola (PK)
NYSE
AMC
AMC Entertainment
USOTC
RDGL
Vivos (QB)
USOTC
RNVA
Rennova Health (CE)
NYSE
IONQ
IonQ
NASDAQ
SMCI
Super Micro Computer
USOTC
PSRU
Valiant Eagle (PK)
USOTC
CNNA
Cann American (CE)
USOTC
QSEP
QS Energy (PK)
USOTC
GRLF
Green Leaf Innovations (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads